This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Aetiology and pathogenesis

Authoring team

  • the aetiology and pathogenesis are poorly understood (1,2,3)

Prior to diagnosis, CFS patients are usually healthy with a good quality of life.

Approximately 50-80% of people with ME/CFS start suddenly with a flu-like illness.

ME/CFS is often found after infection by a virus, bacterium, or parasite, suggesting an immunological dysfunction, along with a genetic predisposition.

Viral involvement is a well-supported theory due to the high index of an infectious onset in at least half of the patients.

  • it is unclear whether infections have a role in the continuing illness or act as a trigger in predisposed individuals
  • other noted triggers include chemotherapy and immunisations
  • CFS patients may show features of other syndromes, particularly fibromyalgia and irritable bowel syndrome. This association suggests that these syndromes may share similar pathogenetic, predisposing or trigger factors

References:

  1. Cortes Rivera M et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review. Diagnostics (Basel). 2019 Aug 7;9(3)
  2. Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management. NICE guideline NG206. (October 2021)
  3. Bested AC, Marshall LM. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Rev Environ Health. 2015;30(4):223-49

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.